Investing in Stocks Made Easy!
at ₹0 Brokerage with 5paisa.
+91
By proceeding, you agree to all T&C*
Investing in Stocks Made Easy!
We've sent a 6-digit verification code to +91 99123918232
Didn't receive the code? Resend
INFOLLION

Infollion Research Services Share Price

 

 

Infollion Research Services live price: ₹195.2. It opened at ₹201 vs previous close ₹200; intraday high/low: ₹201/₹195. The 50 & 200 DMA stand at ₹254.92/₹341.14.

Infollion Research Services Performance

  • Today's Low
  • ₹195
  • Today's High
  • ₹201
  • 52 Week Low
  • ₹190
  • 52 Week High
  • ₹551
  • Open Price₹201
  • Previous Close₹200
  • Volume5,200
  • 50 DMA₹254.92
  • 100 DMA₹297.04
  • 200 DMA₹341.14

Infollion Research Services Chart

Investment Returns

  • Over 1 Month -20.18%
  • Over 3 Month -40.24%
  • Over 6 Month -49.17%
  • Over 1 Year -59.24%

Smart Investing Starts Here Start SIP with Infollion Research Services for Steady Growth!

Invest Now

Infollion Research Services Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 14.9
  • PEG Ratio
  • -
  • Market Cap Cr
  • 190
  • P/B Ratio
  • 3.1
  • Average True Range
  • 12.17
  • EPS
  • 13.1
  • Dividend Yield
  • 0
  • MACD Signal
  • -20.9
  • RSI
  • 26.99
  • MFI
  • 17.21

Infollion Research Services Financials

Infollion Research Services Technicals

EMA & SMA

Current Price
₹195.20
-5.25 (-2.62%)
pointer
  • Bearish Moving Average 16
  • Bullish Moving Average 0
  • 20 Day
  • ₹217.33
  • 50 Day
  • ₹254.92
  • 100 Day
  • ₹297.04
  • 200 Day
  • ₹341.14

Resistance and Support

197.07 Pivot Speed
  • R3 205.13
  • R2 203.07
  • R1 199.13
  • S1 193.13
  • S2 191.07
  • S3 187.13

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Infollion Research Srvs Ltd has an operating revenue of Rs. 177.62 Cr. on a trailing 12-month basis. An annual revenue growth of 30% is outstanding, Pre-tax margin of 17% is great, ROE of 18% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 69 which is a FAIR score but needs to improve its earnings, a RS Rating of 1 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at E which indicates heavy supply, Group Rank of 133 indicates it belongs to a poor industry group of Comml Svcs-Staffing and a Master Score of D is close to being the worst. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Infollion Research Services Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-04-16 Audited Results Inter-alia, to consider 1. Approve the Standalone and Consolidated Audited Financial Results of the Company for the half year and financial year ended March 31, 2026.
2025-10-14 Quarterly Results
2025-04-22 Audited Results
2024-10-14 Quarterly Results
2024-05-06 Audited Results

Infollion Research Services Shareholding Pattern

51.65%
1.03%
33.17%
14.15%

Infollion Research Services FAQs

Infollion Research Services share price is ₹195 As on 25 May, 2026 | 03:29

The Market Cap of Infollion Research Services is ₹189.5 Cr As on 25 May, 2026 | 03:29

The P/E ratio of Infollion Research Services is 14.9 As on 25 May, 2026 | 03:29

The PB ratio of Infollion Research Services is 3.1 As on 25 May, 2026 | 03:29

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23